Americans look to Canada for lower drug prices, but are they getting the full picture?: Nigel Rawson and John Adams in The Hill
This article originally appeared in The Hill. The full article can be read here. By Nigel Rawson and John Adams, ...
Tag: drug policy
Waiting for new drugs for rare disorders in Canada, part 5 – Patented Medicine Prices Review Board: Nigel Rawson and John Adams for Inside Policy
This article is the fifth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada, part 4 – government drug plan listing: Nigel Rawson and John Adams for Inside Policy
This article is the fourth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy
This article is the third part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy
This article is the second part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Top News
-
The equity excellence trade-off: A study of EDI in the Canada Research Chairs Program
-
China is weaponizing the Canada–US trade rift to divide North America: Stephen Nagy for Inside Policy
-
U.S. trade deal dead until Canada stops being the ‘Ugly Ally’: Stephen Nagy in the National Post
-
Gruesome beheading attempt in Belfast a warning against fast-track asylum processes: Michael Barutciski in the National Post
-
What’s at stake in the Canada-U.S. trade deal? How looming tariffs could cost Canada 90,000 jobs: Trevor Tombe in The Hub
